Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HyQvia vs Conventional Subcutaneous Ig Therapy in Multifocal Motor Neuropathy
NCT02556437Phase 2Completed
- Start
- Jun 2016
- Primary completion
- May 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Human normal immunoglobulin G in multifocal motor neuropathy (MMN). Started Jun 2016; status: completed.
02
Drugs
Human normal immunoglobulin G
03
Conditions
multifocal motor neuropathy (MMN)
Beyond the preview
Go deeper on NCT02556437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02556437.